Metropolis Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/05/2025 ,inter alia, to consider and approve the Audited Standalone ....
METROPOLIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Metropolis Healthcare has informed the stock exchanges that its Board of Directors will meet on Tuesday, May 13, 2025. The key agenda is to consider and approve the audited standalone and consolidated financial results for the quarter and full financial year ended March 31, 2025. As per the company's insider trading code, the trading window for its securities has been closed from April 1, 2025 to May 15, 2025 (both days inclusive). No financial figures or outcomes have been disclosed in this filing — it is a procedural advance intimation ahead of the results announcement.
Investors should expect the Q4 and FY25 audited results to be released shortly after May 13, 2025. Until the actual numbers are published, there is no direct impact on the stock price, though the closed trading window means insiders cannot trade until May 15.